Reduced central post-stroke pain, improved vision and improved sensation after multiple strokes following treatment by Edward Tobinick, M.D. Treatment performed and filmed on October 27, 2021 at the Institute of Neurological Recovery in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Perispinal etanercept treatment by Dr. Tobinick. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, on August 30, 2021.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Perispinal etanercept treatment by Dr. Tobinick. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, in August 2021.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Swedish stroke survivor regains ability to walk without assistance and becomes pain-free following perispinal etanercept treatment by Edward Tobinick, M.D. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, August 3, 2021.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Perispinal etanercept treatment by Dr. Tobinick 20 months after stroke. Filmed June 24, 2021, at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Perispinal etanercept treatment by Dr. Tobinick. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, on March 17, 2021. Text, images and video © 2021, INR PLLC, all rights reserved.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Immediate improvement in pain and spasticity following perispinal etanercept treatment by Dr. Tobinick more than 8 years after the stroke occurred.
Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, on January 14, 2021. “It feels like if I took a whole bunch of pain pills that’s how much the pain is gone right now.”
Text, images and video © 2021, INR PLLC, all rights reserved.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Rapid and sustained improvement in speech, ability to walk, hand function, foot pain, spasticity, range of motion and swallowing following perispinal etanercept treatment by Dr. Tobinick. Treatment was given more than 3 years after the stroke occurred.
Text, images and video © 2021, INR PLLC, all rights reserved.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Perispinal etanercept treatment by Dr. Tobinick. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, March 2020.
Text, images and video © 2020, INR PLLC, all rights reserved.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
4 years after brainstem stroke, improvements in chronic central post-stroke pain and less difficulty in swallowing immediately following perispinal etanercept treatment by Dr. Tobinick, February 28, 2020.
Text, images and video © 2020, INR PLLC, all rights reserved.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use